Form4insider filings, from the source

SEC Form 4 · accession 0001140361-17-029602

Sienna Biopharmaceuticals, Inc. · SNNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Clinton Bybee
10% Owner
Period of report
Aug 1, 2017
Accepted (ET)
Aug 1, 2017 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001656328

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 1, 2017C2,538,641—A2,538,641ISee Footnote
Common StockF1,F2Aug 1, 2017C211,934—A2,750,575ISee Footnote
Common StockF1,F3Aug 1, 2017C563,072—A563,072ISee Footnote
Common StockF1,F3Aug 1, 2017C319,421—A882,493ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A-3 Preferred StockF1,F2,F4—Aug 1, 2017C2,538,641D——Common Stock2,538,6410I
Series A-3 Preferred StockF1,F3,F4—Aug 1, 2017C563,072D——Common Stock563,0720I
Series B Preferred StockF1,F2,F4—Aug 1, 2017C211,934D——Common Stock211,9340I
Series B Preferred StockF1,F3,F4—Aug 1, 2017C319,421D——Common Stock319,4210I

Explanation of responses